HLT: HLT, Inc. gains FDA approval for 2 TAVR clinical studies

HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic valve replacement (TAVR) therapy, announced today that it has received U.S. Food and Drug Administration (FDA) approval for two clinical studies to assess the performance and safety of its HLT Meridian TAVR Valve System to treat aortic stenosis [...] The post HLT®, Inc. gains FDA approval for 2 TAVR clinical studies appeared first on Medical Buyer.